Advertisement
Advertisement
U.S. Markets open in 6 hrs 50 mins
Advertisement
Advertisement
Advertisement
Advertisement

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.63000.0000 (0.00%)
At close: 03:58PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/23/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 325.0000
52 Week Low 31.3800
50-Day Moving Average 32.1873
200-Day Moving Average 37.4498

Share Statistics

Avg Vol (3 month) 3354.51k
Avg Vol (10 day) 322.65k
Shares Outstanding 59.08M
Implied Shares Outstanding 6N/A
Float 811.05M
% Held by Insiders 155.90%
% Held by Institutions 182.18%
Shares Short (Jan 12, 2023) 425.74k
Short Ratio (Jan 12, 2023) 40.04
Short % of Float (Jan 12, 2023) 4N/A
Short % of Shares Outstanding (Jan 12, 2023) 40.28%
Shares Short (prior month Dec 14, 2022) 413.58k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.41M
Net Income Avi to Common (ttm)-21.43M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)602.75k
Total Cash Per Share (mrq)0.03
Total Debt (mrq)3.96M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.16
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-1.69M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement